Unaudited Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2020		Dec. 31, 2019
Current Assets
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 570		$ 463
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2020: $10; 2019: $9; variable interest entity restricted - 2020: $4; 2019: $6)	853		850
Non-trade receivables, net	307		331
Inventories	1,036		1,038
Marketable securities	38		40
Other assets	51		43
Total current assets	2,855		2,765
Investments in affiliates	981		975
Property, plant and equipment (net of accumulated depreciation - 2020: $3,001; 2019: $2,957; variable interest entity restricted - 2020: $619; 2019: $622)	3,678		3,713
Operating Lease, Right-of-Use Asset	201		203
Deferred income taxes	91		96
Other assets (variable interest entity restricted - 2020: $17; 2019: $9)	381		338
Goodwill	1,056	[1]	1,074
Intangible assets (variable interest entity restricted - 2020: $22; 2019: $22)	302		312
Total assets	9,545		9,476
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	749		496
Trade payables - third party and affiliates	724		780
Other liabilities	422		461
Income taxes payable	33		17
Total current liabilities	1,928		1,754
Long-term debt, net of unamortized deferred financing costs	3,356		3,409
Deferred income taxes	258		257
Uncertain tax positions	161		165
Benefit obligations	568		589
Operating Lease, Liability, Noncurrent	175		181
Other liabilities	263		223
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2020 and 2019: 0 issued and outstanding)	0		0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2020: 169,356,294 issued and 118,228,898 outstanding; 2019: 168,973,172 issued and 119,555,207 outstanding)	0		0
Treasury stock, at cost (2020: 51,127,396 shares; 2019: 49,417,965 shares)	(3,996)		(3,846)
Additional paid-in capital	242		254
Retained earnings	6,543		6,399
Accumulated other comprehensive income (loss), net	(341)		(300)
Total Celanese Corporation stockholders' equity	2,448		2,507
Noncontrolling interests	388		391
Total equity	2,836		2,898
Total liabilities and equity	$ 9,545		$ 9,476

[1] There were $0 million of accumulated impairment losses as of March 31, 2020.